Literature DB >> 6767845

Treatment of tuberculosis. The Mitchell lecture 1979.

D A Mitchison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6767845      PMCID： PMC5373312     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN： 0035-8819


× No keyword cloud information.
  9 in total

1.  Antituberculous therapy in children.

Authors:  V Seth
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

2.  Current concepts in the treatment of tuberculosis.

Authors:  I B Tager
Journal:  West J Med       Date:  1987-04

3.  Short course chemotherapy for tuberculosis in children.

Authors:  B L Varudkar
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

4.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

5.  Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.

Authors:  R Dawson; K Narunsky; D Carman; N Gupte; A Whitelaw; A Efron; G L Barnes; J Hoffman; R E Chaisson; H McIlleron; S E Dorman
Journal:  Int J Tuberc Lung Dis       Date:  2015-07       Impact factor: 2.373

6.  Lack of fusion of azurophil granules with phagosomes during phagocytosis of Mycobacterium smegmatis by human neutrophils is not actively controlled by the bacterium.

Authors:  Céline Cougoule; Patricia Constant; Gilles Etienne; Mamadou Daffé; Isabelle Maridonneau-Parini
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

8.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

Review 9.  One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.

Authors:  Hee-Jeong Yang; Decheng Wang; Xin Wen; Danielle M Weiner; Laura E Via
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.